OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
ORAGENICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.42−0.01 (-2.97%)
Close on Oct 19, 2026
- Market cap
- $1.87M
- P/E (TTM)
- –
- Dividend yield
- –
Oragenics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Oragenics | Industry median |
|---|---|---|
| Market Cap | $1.90M | $197.05M |
| Enterprise Value | -$1.96M | $106.56M |
| PB Ratio | 0.52 | 2.14 |
| P/TBV Ratio | 0.52 | 2.46 |
Income (trailing twelve months)
| Measure | Oragenics | Industry median |
|---|---|---|
| Operating Income | -$10.47M | -$21.44M |
| Net Income | -$10.08M | -$22.46M |
| EBITDA | -$10.47M | -$16.91M |
Returns
| Measure | Oragenics | Industry median |
|---|---|---|
| Return on Equity (ROE) | -1307.1% | -53.1% |
| Return on Assets (ROA) | -264.2% | -41.0% |
Balance sheet
| Measure | Oragenics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $3.86M | $62.42M |
| Net Cash (Debt) | $3.86M | $15.68M |
| Net Cash Per Share | $0.86 | $0.65 |
| Equity (Book Value) | $3.67M | $48.79M |
| Book Value Per Share | $0.81 | $1.36 |
| Tangible Book Value | $3.67M | $23.06M |
Financial position
| Measure | Oragenics | Industry median |
|---|---|---|
| Interest Coverage | -561.90 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Oragenics | Industry median |
|---|---|---|
| Operating Cash Flow | -$10.21M | -$12.35M |
Efficiency
| Measure | Oragenics | Industry median |
|---|---|---|
| Profits Per Employee | -$3.36M | -$732.08K |
| Employee Count | 3 | 73 |
Dividends and yields
| Measure | Oragenics | Industry median |
|---|---|---|
| Earnings Yield | -529.6% | -21.2% |
| Buyback Yield | -4.10% | -0.58% |
| Shareholder Yield | -4.10% | 0.00% |
Shares
| Measure | Oragenics | Industry median |
|---|---|---|
| Shares Outstanding | 4,511,960 | 59,128,900 |
| Shares Change (QoQ) | 3.11% | 0.54% |
| Float | 4,393,560 | 48,744,500 |
| Shares Held by Insiders | 2.62% | 11.8% |
| Shares Held by Institutions | 1.50% | 59.4% |
Scores
| Measure | Oragenics | Industry median |
|---|---|---|
| Altman Z-Score | -64.64 | 0.10 |
Calculated by StockData from Oragenics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.